Table 1.
Applications of TCMPs in DDS
Polysaccharide | DDS composition | Form | Function | Application | Ref. |
---|---|---|---|---|---|
BSP | DTX-SA-BSP | Copolymer micelle | Sustained release, pH sensitive, promoting absorption, enhancing stability | Anticancer | [31] |
BSP | SM-hm-BSP | Copolymer micelle | Sustained release | Hepatic-targeted drug delivery | [32] |
APS | APS-CMC-BSA | Hydrogel | Sustained release | – | [40] |
BSP | PNS-BSP/alginate | Bioadhesive microsphere | Sustained release, synergistic effect | Gastric ulcers | [11, 17] |
GLP | RCGDDH NPs | Conjugate | Redox and pH dual-responsive, synergistic effect | Anticancer | [16] |
LBP | LBP-5ASA-Pt | Conjugate | Passive targeting (EPR) | Anti-lung cancer | [51] |
BSP | Dox@FA-BSP-SA/TPGS | Copolymer micelle | FA-mediated active targeting, synergistic effect | Anticancer | [47] |
BSP | DTX-BSP-ss-SA | Copolymer micelle | Redox and pH dual-responsive | Anticancer | [59] |
ASP | DOX/ASP-DOCA | Copolymer micelle | pH sensitive, ASGPR-mediated active targeting | Hepatic-targeted drug delivery | [56] |
ASP | Cur/ACNPs | Copolymer micelle | ASGPR-mediated active targeting | ALD | [45] |
APS | quercetin-APS | Conjugate | Solubilization | – | [65] |
VBCP | Baicalin/rhein-VBCP | Copolymer micelle | Solubilization | – | [63] |
GPs | Ag-GPs | Nanoparticle | Enhancing stability | Antimicrobial biomaterials | [72] |
ASP | AS-PBA/GA-CDB@Cur | Nanoparticle | Enhancing stability, pH sensitive | Antitumor | [83] |
RP | CP3-DOX | Nanoparticle | Enhancing stability, promoting absorption, pH sensitive | Antitumor | [79] |
BSP | LP-OBSP-CS | Hydrogel | Enhancing stability | Wound healing | [81] |
OJP | THSG-OJP | Complexes | Enhancing solubility and stability | – | [64] |
BSP | RB-BMNs | – | effective transdermal drug delivery | – | [94] |
APS | Se-APS | Nanoparticle | Promoting absorption | Micro nutrient | [89] |
LP | LP-Se | Nanoparticle | Promoting absorption | Anticancer | [90] |